Meliessa Hennessy

Efficacy and Safety of First-line Avelumab Treatment in Patients With Stage IV Metastatic Merkel Cell Carcinoma

Sandra P. D’Angelo, Jeffery S. Russell, Célèste Lebbé et al. · JAMA Oncology · 2018 · 368 citations · Full text

Medicine, Oncology, Pharmacology +17

Updated efficacy of avelumab in patients with previously treated metastatic Merkel cell carcinoma after ≥1 year of follow-up: JAVELIN Merkel 200, a phase 2 clinical trial

Howard L. Kaufman, Jeffery S. Russell, Omid Hamid et al. · Journal for ImmunoTherapy of Cancer · 2018 · 330 citations · Full text

Medicine, Oncology, Pharmacology +17

Ponatinib vs Imatinib in Frontline Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia

Elias Jabbour, Hagop M. Kantarjian, Ibrahim Aldoss et al. · JAMA · 2024 · 114 citations · Full text

Medicine, Oncology, Pharmacology +12

Two-year efficacy and safety update from JAVELIN Merkel 200 part A: A registrational study of avelumab in metastatic Merkel cell carcinoma progressed on chemotherapy.

Paul Nghiem, Shailender Bhatia, Andrew S. Brohl et al. · Journal of Clinical Oncology · 2018 · 47 citations

Medicine, Oncology, Pharmacotherapy +17

Benefits and Challenges in Use of a Standardized Symptom Assessment Instrument in Hospice

Dena Schulman‐Green, Emily Cherlin, Ruth McCorkle et al. · Journal of Palliative Medicine · 2009 · 30 citations · Full text

Nursing, Health Administration, Health Assessment +16